ArticleThe Journal of urology2024

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.

Surena F Matin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.